This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Brain Imaging And Neuroimaging Market

Rising Incidence and Prevalence of Neurological Disorders to Generate a Plethora of Investment Opportunities

Brain Imaging and Neuroimaging Market by Imaging Type, End User & Region - Forecast 2022 - 2032

Brain Imaging and Neuroimaging Market Snapshot (2022-2032)

[291 Pages Report] The global brain imaging and neuroimaging market is expected to be worth US$ 13,166.5 Million by 2022, and is likely to grow at a moderate CAGR of 5.1% between 2022 and 2032, totalling around US$ 21,569.7 Million by 2032.

Report Attribute

Details

Expected Market Value (2022)

US$ 13,166.5 Million

Anticipated Forecast Value (2032)

US$ 21,569.7 Million

Projected Growth Rate (2022-2032)

5.1% CAGR

The brain imaging and neuroimaging market is primarily driven by factors such as the rising incidence and prevalence of neurological disorders, increased awareness of neurodegenerative diseases, an increase in the number of traumatic brain injuries, and increased applications of brain imaging and neuroimaging in clinical trials.

Rising demand for non-invasive and minimally invasive devices, expanding therapeutic applications of brain imaging and neuroimaging devices, and the expanding healthcare market in emerging economies are all expected to provide growth opportunities for market participants.

Customize this Report

Let us know your requirement to get
100% FREE customization

Brain Imaging and Neuroimaging Demand Analysis (2016 to 2021) Vs Market Outlook (2022 to 2032)

The global demand for brain imaging and neuroimaging is projected to increase at a CAGR of 5.1% during the forecast period between 2022 and 2032, reaching a total of US$ 21,569.7 Million in 2032, according to a report from Future Market Insights (FMI). From 2016 to 2021, sales witnessed significant growth, registering a CAGR of 4.8%.

The growing prevalence of neurological disorders, the growing geriatric population, and emerging product trends are some of the factors driving market growth. The rising prevalence of neurological disorders, combined with an ageing population that is more prone to developing neurodegenerative diseases such as Parkinson's, Alzheimer's, dementia, epilepsy, and others, are expected to drive growth in brain imaging and neuroimaging market.

Furthermore, the growing global geriatric population is expected to play a significant role in the growth of the studied market because they are more vulnerable to various neurological disorders and injuries as they age, and when combined with new technological advancements, the studied market is forecasted to grow during the projected period. However, a scarcity of skilled professionals is expected to limit the brain imaging and neuroimaging market’s growth over the projected period.

Which are Some Prominent Drivers of Brain Imaging and Neuroimaging Market?

Rising Global Incidence of Brain Cancer to Promote Market Growth

The rising global incidence of brain cancer, combined with rising rates of neurodegenerative disorders, is expected to fuel the growth of the global brain imaging market. The introduction of innovative products by key imaging segment players is also expected to drive the overall brain imaging and neuroimaging market.

Furthermore, increasing road accidents around the world are anticipated to drive the market during the forecast period. One of the drivers expected to increase the revenue of the brain imaging market is technological advancements in imaging techniques and the availability of reimbursement programmes for various types of imaging tests, including brain imaging.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Challenges Faced by the Brain Imaging and Neuroimaging Market?

High Cost of Imaging Techniques to Impede Market Growth

The high cost of imaging techniques is a major impediment to the growth of the global brain imaging and neuroimaging market. Furthermore, one of the market restraints for brain imaging is a dearth of awareness and the absence of scanners in remote areas.

Region-Wise Insights

What Makes the North America the Largest Market for Brain Imaging and Neuroimaging?

Rise in Disease Prevalence Creating Opportunities for Brain Imaging and Neuroimaging manufacturers

Over the forecast period, North America is expected to have the largest market share. The rise in funding for various neurodegenerative disease researches, the rise in disease prevalence and awareness, and the presence of key market players are the major factors contributing to the growth of the studied market. According to the Parkinson's Foundation, approximately one million people in the United States will have Parkinson's disease (PD) by the end of 2020, and nearly 60,000 Americans are diagnosed with Parkinson's disease each year.

Increasing funding is a critical factor in market expansion. Nearly one million people in the United States will have Parkinson's disease (PD) in 2020. According to the same source, approximately 60,000 Americans are diagnosed with Parkinson's disease each year. As a result, the prevalence of Parkinson's disease rises with age, but an estimated 4% of people with the disease are diagnosed before the age of 50.

According to the National Institute of Health, funding for neurodegenerative diseases was USD 4,021 million in 2020, and it is expected to increase to USD 4,110 million in 2021. Rising research funding is expected to attract the majority of the major players, resulting in rapid growth of the market under consideration. Thus, due to the aforementioned reasons, North America is expected to possess 37.8% market share in 2022, registering a CAGR of 5% for Brain Imaging and Neuroimaging market in the assessment period 2022-2032.

Why Western Europe is considered a Lucrative Market for Brain Imaging and Neuroimaging?

Increasing Prevalence of Brain Cancer favouring market growth

Because of the increasing prevalence of brain cancer and neurodegenerative disorders, Western Europe is expected to dominate the overall brain imaging market over the forecast period. Thus, Europe is expected to hold 35.3% of market share for Brain Imaging and Neuroimaging market in 2022.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-Wise Insights

Which is the Dominant End User in the Brain Imaging and Neuroimaging Market?

Hospitals to hold the Lion’s Share in the Brain Imaging and Neuroimaging Market

End-users in the global brain imaging and neuroimaging market include hospitals, ambulatory surgical centres and clinics and diagnostic centres. In 2020, the hospital segment held the largest share of the brain imaging and neuroimaging market. Brain imaging and neuroimaging is a complex process that necessitates the use of expensive and sophisticated devices and equipment typically found in hospitals.

In addition, hospitals receive significantly more patients than small clinics and other end users. Furthermore, brain imaging and neuroimaging impose a significant burden on healthcare facilities in terms of maintenance costs; hospitals, more than other end-users, can bear such costs. As a result, brain imaging and neuroimaging are mostly used in hospitals, which account for the lion's share of this market segment.

Which is the Leading Imaging Type in the Brain Imaging and Neuroimaging Market?

Brain Imaging to have the Highest Demand in the Market

In recent years, the healthcare industry has seen technological advances in medical devices that provide robust services to patients suffering from brain-related diseases. Brain imaging is currently one of the fastest growing segments of the overall imaging market.

Brain imaging is a screening method that allows doctors to analyse the activity and functioning of the nervous system in order to treat various types of neurodegenerative disorders. There are various types of scanners available on the market to provide services in the brain imaging segment. Brain imaging devices include functional magnetic resonance imaging (fMRI), computed tomography (CT), positron emission tomography (PET), electroencephalography (EEG), magnetoencephalography (MEG), and near-infrared spectroscopy (NIRS).

Among these, functional magnetic resonance imaging (fMRI) is well-known for providing detailed information about brain activity by detecting changes in blood oxygenation. Anatomical and functional information about changes in blood flow to specific areas of the brain are also provided by functional magnetic resonance imaging (fMRI). Brain imaging is widely used in the diagnosis of neurodegenerative diseases like Alzheimer's and Parkinsonism, as well as chronic diseases like brain cancer.

Start-Ups for Brain Imaging and Neuroimaging Market

Key startup players in the Brain Imaging and Neuroimaging market are:

  • KinePict, based in Budapest, is a medical software company that makes X-ray imaging more powerful and safer. The patented technology of the company extracts motion-related functional information from X-ray image series and displays it as a kinetic image. The additional information obtained aids in the diagnosis of moving organs. Furthermore, by reducing contrast material and X-ray dose, kinetic imaging may make fluoroscopy and angiography safer.
  • icometrix, based in Leuven, has created FDA-approved and CE-certified icobrain software. The company claims that its icobrain software allows for a more consistent and personalized understanding of medical images by quantifying the volume of brain structures and abnormalities. This software is critical because brain scans play an important role in the accurate diagnosis and treatment of various disorders.
  • Galgo Medical is a Universitat Pompeu Fabra spin-off that creates medical imaging software. It provides low-cost pathways for the development of advanced medical technology solutions. Galgo Medical provides an efficient means of bringing these solutions to the expanding global market. This is made possible by its in-house software development platform, which is designed for rapid prototyping of medical imaging applications.

Market Competition

Key players in the brain imaging and neuroimaging market include Varian Medical Systems, General Electric Company, Siemens AG, Philips Healthcare, and Toshiba Medical Systems, Hitachi Medical systems, Esaote SpA and Sanrad Medical Systems Pvt. Ltd.

  • In August 2022, Siemens Smart Infrastructure (SI), the market leader in digital buildings, has completed the acquisition of Brightly Software, a leading asset and maintenance management software-as-a-service (SaaS) provider based in the United States. The acquisition propels SI to the forefront of the software market for buildings and built infrastructure. It combines Brightly's well-established cloud-based capabilities in key sectors such as education, public infrastructure, healthcare, and manufacturing with Siemens' digital and software expertise in buildings.
  • In August 2022, Ernst & Young LLP (EY US) and GE Digital have announced a partnership to assist organisations in transforming their manufacturing operations. The alliance brings together EY US's proven sector expertise and technology consulting services with GE's more than 100 years of manufacturing experience and rich digital technology.
  • In June 2022, Toshiba Electronics Europe GmbH, its European sales and marketing subsidiary, announces the extension of its relationship with Farnell, a global distributor of electronic components, products, and solutions known as Farnell in Europe, Newark in North America, and element in Asia Pacific. Farnell will stock more Toshiba products in larger quantities as a result of this agreement, increasing their support of Toshiba's customer supply chain.
  • In April 2022, Varian, a Siemens Healthineers company, announced a five-year research and professional services agreement with Icon Group (Icon). Icon will participate in clinical and technical research programmes, product evaluation projects, and clinical consultations with Varian under this agreement in order to provide clinical expertise and industry perspectives throughout product development.

Report Scope

Report Attribute

Details

Market Value in 2022

US$ 13,166.5 Million

Market Value in 2032

US$ 21,569.7 Million

Growth Rate

CAGR of 5.1% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2016-2021

Forecast Period

2022-2032

Quantitative Units

Revenue in US$ Million and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Imaging Type
  • End User
  • Region

Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Argentina
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Russia
  • India
  • Thailand
  • Indonesia
  • Malaysia
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • GCC
  • South Africa

Key Companies Profiled

Customization

Available Upon Request

Key Segments Profiled in the Brain Imaging and Neuroimaging Industry Survey

Brain Imaging and Neuroimaging Market by Imaging Type:

  • Functional Magnetic Resonance Imaging (fMRI)
  • Computed Tomography (CT)
  • Positron Emission Tomography (PET)
  • Electroencephalography (EEG)
  • Magnetoencephalography (MEG)
  • Near Infrared Spectroscopy (NIRS)

Brain Imaging and Neuroimaging Market by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics and Diagnostic Centers

Brain Imaging and Neuroimaging Market by Region:

  • North America Brain Imaging and Neuroimaging Market
  • Latin America Brain Imaging and Neuroimaging Market
  • Europe Brain Imaging and Neuroimaging Market
  • East Asia Brain Imaging and Neuroimaging Market
  • South Asia Brain Imaging and Neuroimaging Market
  • Oceania Brain Imaging and Neuroimaging Market
  • Middle East and Africa Brain Imaging and Neuroimaging Market

Frequently Asked Questions

FMI projects the global brain imaging and neuroimaging market to expand at a 5.1% value CAGR by 2032

The global brain imaging and neuroimaging market is estimated at a market value of US$ 13,166.5 Million

The global brain imaging and neuroimaging market is expected to garner a market value of US$ 21,569.7 Million

North America is expected to possess 37.8% market share in 2022 in the brain imaging and neuroimaging market

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions/Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Imaging Type modifications /Innovation

4. Key Success Factors

    4.1. Strategic Developments

    4.2. Key regulations

    4.3. Imaging Type USPs /Technology

    4.4. List of Manufacturers and Providers

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP outlook

        5.1.2. Increasing R&D Expenditure

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. New Imaging Type launches

        5.2.2. Cost of Imaging Types

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. Global Brain Imaging and Neuroimaging Market Volume (Units) Analysis 2016-2021 and Forecast, 2022-2032

    6.1. Historical Market Volume (Units) Analysis, 2016-2021

    6.2. Current and Future Market Volume (Units) Projections, 2022-2032

        6.2.1. Y-o-Y Growth Trend Analysis

7. Global Brain Imaging and Neuroimaging Market - Pricing Analysis

    7.1. Regional Pricing Analysis By Imaging Type

    7.2. Pricing Break-up

        7.2.1. Manufacturer Level Pricing

        7.2.2. Distributor Level Pricing

    7.3. Global Average Pricing Analysis Benchmark

8. Global Brain Imaging and Neuroimaging Market Value Analysis 2016–2021 and Forecast, 2022-2032

    8.1. Historical Market Value (US$ Mn) Analysis, 2016–2021

    8.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

9. Global Brain Imaging and Neuroimaging Market Analysis 2016–2021 and Forecast 2022-2032, by Imaging Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Imaging Types & Services, 2016–2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Imaging Type, 2022-2032

        9.3.1. Functional Magnetic Resonance Imaging (fMRI)

        9.3.2. Computed Tomography (CT)

        9.3.3. Positron Emission Tomography (PET)

        9.3.4. Electroencephalography (EEG)

        9.3.5. Magnetoencephalography (MEG)

        9.3.6. Near Infrared Spectroscopy (NIRS)

    9.4. Market Attractiveness Analysis By Imaging Type

10. Global Brain Imaging and Neuroimaging Market Analysis 2016–2021 and Forecast 2022-2032, by End User

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By End User , 2016–2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User , 2022-2032

        10.3.1. Hospitals

        10.3.2. Ambulatory Surgical Centers

        10.3.3. Clinics & Diagnostic Centers

    10.4. Market Attractiveness Analysis By End User

11. Global Brain Imaging and Neuroimaging Market Analysis 2016–2021 and Forecast 2022-2032, by Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2016–2021

    11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2032

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. East Asia

        11.3.5. South Asia

        11.3.6. Oceania

        11.3.7. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Brain Imaging and Neuroimaging Market Analysis 2016–2021 and Forecast 2022-2032

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021

    12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.3.1. By Country

            12.3.1.1. U.S.

            12.3.1.2. Canada

        12.3.2. By Imaging Type

        12.3.3. By End User

    12.4. Market Attractiveness Analysis

    12.5. Key Market Participants - Intensity Mapping

    12.6. Drivers and Restraints - Impact Analysis

13. Latin America Brain Imaging and Neuroimaging Market Analysis 2016–2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.3.1. By Country

            13.3.1.1. Brazil

            13.3.1.2. Mexico

            13.3.1.3. Argentina

            13.3.1.4. Rest of Latin America

        13.3.2. By Imaging Type

        13.3.3. By End User

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Europe Brain Imaging and Neuroimaging Market Analysis 2016–2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        14.3.1. By Country

            14.3.1.1. Germany

            14.3.1.2. Italy

            14.3.1.3. France

            14.3.1.4. U.K.

            14.3.1.5. Spain

            14.3.1.6. Russia

            14.3.1.7. Rest of Europe

        14.3.2. By Imaging Type

        14.3.3. By End User

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. South Asia Brain Imaging and Neuroimaging Market Analysis 2016–2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        15.3.1. By Country

            15.3.1.1. India

            15.3.1.2. Thailand

            15.3.1.3. Indonesia

            15.3.1.4. Malaysia

            15.3.1.5. Rest of South Asia

        15.3.2. By Imaging Type

        15.3.3. By End User

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. East Asia Brain Imaging and Neuroimaging Market Analysis 2016–2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021

    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        16.3.1. By Country

            16.3.1.1. China

            16.3.1.2. Japan

            16.3.1.3. South Korea

            16.3.1.4. Rest of East Asia

        16.3.2. By Imaging Type

        16.3.3. By End User

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. Oceania Brain Imaging and Neuroimaging Market Analysis 2016–2021 and Forecast 2022-2032

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021

    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        17.3.1. By Country

            17.3.1.1. Australia

            17.3.1.2. New Zealand

        17.3.2. By Imaging Type

        17.3.3. By End User

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Brain Imaging and Neuroimaging Market Analysis 2016–2021 and Forecast 2022-2032

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021

    18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        18.3.1. By Country

            18.3.1.1. GCC Countries

            18.3.1.2. South Africa

            18.3.1.3. Rest of Middle East and Africa

        18.3.2. By Imaging Type

        18.3.3. By End User

    18.4. Market Attractiveness Analysis

    18.5. Drivers and Restraints - Impact Analysis

19. Key and Emerging Countries Brain Imaging and Neuroimaging Market Analysis 2016–2021 and Forecast 2022-2032

    19.1. Introduction

        19.1.1. Market Value Proportion Analysis, By Key Countries

        19.1.2. Global Vs. Country Growth Comparison

    19.2. U.S. Brain Imaging and Neuroimaging Market Analysis

        19.2.1. By Imaging Type

        19.2.2. By End User

    19.3. Canada Brain Imaging and Neuroimaging Market Analysis

        19.3.1. By Imaging Type

        19.3.2. By End User

    19.4. Mexico Brain Imaging and Neuroimaging Market Analysis

        19.4.1. By Imaging Type

        19.4.2. By End User

    19.5. Brazil Brain Imaging and Neuroimaging Market Analysis

        19.5.1. By Imaging Type

        19.5.2. By End User

    19.6. U.K. Brain Imaging and Neuroimaging Market Analysis

        19.6.1. By Imaging Type

        19.6.2. By End User

    19.7. Germany Brain Imaging and Neuroimaging Market Analysis

        19.7.1. By Imaging Type

        19.7.2. By End User

    19.8. France Brain Imaging and Neuroimaging Market Analysis

        19.8.1. By Imaging Type

        19.8.2. By End User

    19.9. Italy Brain Imaging and Neuroimaging Market Analysis

        19.9.1. By Imaging Type

        19.9.2. By End User

    19.10. Spain Brain Imaging and Neuroimaging Market Analysis

        19.10.1. By Imaging Type

        19.10.2. By End User

    19.11. BENELUX Brain Imaging and Neuroimaging Market Analysis

        19.11.1. By Imaging Type

        19.11.2. By End User

    19.12. Russia Brain Imaging and Neuroimaging Market Analysis

        19.12.1. By Imaging Type

        19.12.2. By End User

    19.13. China Brain Imaging and Neuroimaging Market Analysis

        19.13.1. By Imaging Type

        19.13.2. By End User

    19.14. Japan Brain Imaging and Neuroimaging Market Analysis

        19.14.1. By Imaging Type

        19.14.2. By End User

    19.15. South Korea Brain Imaging and Neuroimaging Market Analysis

        19.15.1. By Imaging Type

        19.15.2. By End User

    19.16. India Brain Imaging and Neuroimaging Market Analysis

        19.16.1. By Imaging Type

        19.16.2. By End User

    19.17. ASEAN Brain Imaging and Neuroimaging Market Analysis

        19.17.1. By Imaging Type

        19.17.2. By End User

    19.18. Australia Brain Imaging and Neuroimaging Market Analysis

        19.18.1. By Imaging Type

        19.18.2. By End User

    19.19. New Zealand Brain Imaging and Neuroimaging Market Analysis

        19.19.1. By Imaging Type

        19.19.2. By End User

    19.20. GCC Countries Brain Imaging and Neuroimaging Market Analysis

        19.20.1. By Imaging Type

        19.20.2. By End User

    19.21. Turkey Brain Imaging and Neuroimaging Market Analysis

        19.21.1. By Imaging Type

        19.21.2. By End User /p>

    19.22. South Africa Brain Imaging and Neuroimaging Market Analysis

        19.22.1. By Imaging Type

        19.22.2. By End User

20. Market Structure Analysis

    20.1. Market Analysis by Tier of Companies

    20.2. Market Concentration

    20.3. Market Share Analysis of Top Players

    20.4. Market Presence Analysis

        20.4.1. By Regional footprint of Players

        20.4.2. Imaging Type foot print by Players

        20.4.3. Channel Foot Print by Players

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Benchmarking

    21.3. Competition Deep dive

        21.3.1. Varian Medical Systems

            21.3.1.1. Overview

            21.3.1.2. Imaging Type Portfolio

            21.3.1.3. Profitability by Market Segments (Imaging Type/Channel/Region)

            21.3.1.4. Sales Footprint

            21.3.1.5. Strategy Overview

        21.3.2. General Electric Company

            21.3.2.1. Overview

            21.3.2.2. Imaging Type Portfolio

            21.3.2.3. Profitability by Market Segments (Imaging Type/Channel/Region)

            21.3.2.4. Sales Footprint

            21.3.2.5. Strategy Overview

        21.3.3. Siemens AG

            21.3.3.1. Overview

            21.3.3.2. Imaging Type Portfolio

            21.3.3.3. Profitability by Market Segments (Imaging Type/Channel/Region)

            21.3.3.4. Sales Footprint

            21.3.3.5. Strategy Overview

        21.3.4. Philips Healthcare

            21.3.4.1. Overview

            21.3.4.2. Imaging Type Portfolio

            21.3.4.3. Profitability by Market Segments (Imaging Type/Channel/Region)

            21.3.4.4. Sales Footprint

            21.3.4.5. Strategy Overview

        21.3.5. Toshiba Medical Systems

            21.3.5.1. Overview

            21.3.5.2. Imaging Type Portfolio

            21.3.5.3. Profitability by Market Segments (Imaging Type/Channel/Region)

            21.3.5.4. Sales Footprint

            21.3.5.5. Strategy Overview

        21.3.6. Hitachi Medical Systems

            21.3.6.1. Overview

            21.3.6.2. Imaging Type Portfolio

            21.3.6.3. Profitability by Market Segments (Imaging Type/Channel/Region)

            21.3.6.4. Sales Footprint

            21.3.6.5. Strategy Overview

        21.3.7. Easote S.p.A

            21.3.7.1. Overview

            21.3.7.2. Imaging Type Portfolio

            21.3.7.3. Profitability by Market Segments (Imaging Type/Channel/Region)

            21.3.7.4. Sales Footprint

            21.3.7.5. Strategy Overview

        21.3.8. Sanrad Medical Systems Pvt. Ltd.

            21.3.8.1. Overview

            21.3.8.2. Imaging Type Portfolio

            21.3.8.3. Profitability by Market Segments (Imaging Type/Channel/Region)

            21.3.8.4. Sales Footprint

            21.3.8.5. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Brain Imaging and Neuroimaging Market Volume (‘000 Units) Analysis and Opportunity Assessment 2016–2032, By Imaging Type

Table 02: Global Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Imaging Type

Table 03: Global Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By End User

Table 04: Global Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Region

Table 05: North America Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country

Table 06: North America Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Imaging Type

Table 07: North America Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By End User

Table 08: Latin America Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country

Table 09: Latin America Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Imaging Type

Table 10: Latin America Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By End User

Table 11: Europe Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country

Table 12: Europe Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Imaging Type

Table 13: Europe Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By End User

Table 14: South Asia Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country

Table 15: South Asia Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Imaging Type

Table 16: South Asia Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By End User

Table 17: East Asia Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country

Table 18: East Asia Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Imaging Type

Table 19: East Asia Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By End User

Table 20: Oceania Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country

Table 21: Oceania Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Imaging Type

Table 22: Oceania Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By End User

Table 23: Middle East and Africa Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country

Table 24: Middle East and Africa Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Imaging Type

Table 25: Middle East and Africa Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Brain Imaging and Neuroimaging Market Volume (in 000' Units) Analysis, 2016-2021

Figure 02: Global Brain Imaging and Neuroimaging Market Volume Forecast (in 000' Units), 2022-2032

Figure 03: Brain Imaging and Neuroimaging Pricing Analysis (US$) Per Imaging Type, By Region, 2021

Figure 04: Brain Imaging and Neuroimaging Pricing Analysis (US$) Per Imaging Type, By Region, 2021

Figure 05: Global Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2016-2021

Figure 06: Global Brain Imaging and Neuroimaging Market Value Forecast (US$ Mn), 2022-2032

Figure 07: Global Brain Imaging and Neuroimaging Market Absolute $ Opportunity, 2022-2032

Figure 08: Global Brain Imaging and Neuroimaging Market Share Analysis (%), By Imaging Type, 2022-2032

Figure 09: Global Brain Imaging and Neuroimaging Market Y-o-Y Analysis (%), By Imaging Type, 2022-2032

Figure 10: Global Brain Imaging and Neuroimaging Market Attractiveness Analysis by Imaging Type, 2022-2032

Figure 11: Global Brain Imaging and Neuroimaging Market Share Analysis (%), By End User, 2022-2032

Figure 12: Global Brain Imaging and Neuroimaging Market Y-o-Y Analysis (%), By End User, 2022-2032

Figure 13: Global Brain Imaging and Neuroimaging Market Attractiveness Analysis by End User, 2022-2032

Figure 14: Global Brain Imaging and Neuroimaging Market Share Analysis (%), By Region, 2022-2032

Figure 15: Global Brain Imaging and Neuroimaging Market Y-o-Y Analysis (%), By Region, 2022-2032

Figure 16: Global Brain Imaging and Neuroimaging Market Attractiveness Analysis by Region, 2022-2032

Figure 17: North America Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 18: North America Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 19: North America Brain Imaging and Neuroimaging Market Value Share, By Country, 2022 (E)

Figure 20: North America Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2016-2021

Figure 21: North America Brain Imaging and Neuroimaging Market Value Forecast (US$ Mn), 2022-2032

Figure 22: North America Brain Imaging and Neuroimaging Market Attractiveness Analysis by Imaging Type, 2022-2032

Figure 23: North America Brain Imaging and Neuroimaging Market Attractiveness Analysis by End User, 2022-2032

Figure 24: North America Brain Imaging and Neuroimaging Market Attractiveness Analysis by Country, 2022-2032

Figure 25: Latin America Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 26: Latin America Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 27: Latin America Brain Imaging and Neuroimaging Market Value Share, By Country, 2022 (E)

Figure 28: Latin America Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2016-2021

Figure 29: Latin America Brain Imaging and Neuroimaging Market Value Forecast (US$ Mn), 2022-2032

Figure 30: Latin America Brain Imaging and Neuroimaging Market Attractiveness Analysis by Imaging Type, 2022-2032

Figure 31: Latin America Brain Imaging and Neuroimaging Market Attractiveness Analysis by End User, 2022-2032

Figure 32: Latin America Brain Imaging and Neuroimaging Market Attractiveness Analysis by Country, 2022-2032

Figure 33: Europe Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 34: Europe Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 35: Europe Brain Imaging and Neuroimaging Market Value Share, By Country, 2022 (E)

Figure 36: Europe Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2016-2021

Figure 37: Europe Brain Imaging and Neuroimaging Market Value Forecast (US$ Mn), 2022-2032

Figure 38: Europe Brain Imaging and Neuroimaging Market Attractiveness Analysis by Imaging Type, 2022-2032

Figure 39: Europe Brain Imaging and Neuroimaging Market Attractiveness Analysis by End User, 2022-2032

Figure 40: Europe Brain Imaging and Neuroimaging Market Attractiveness Analysis by Country, 2022-2032

Figure 41: South Asia Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 42: South Asia Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 43: South Asia Brain Imaging and Neuroimaging Market Value Share, By Country, 2022 (E)

Figure 44: South Asia Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2016-2021

Figure 45: South Asia Brain Imaging and Neuroimaging Market Value Forecast (US$ Mn), 2022-2032

Figure 46: South Asia Brain Imaging and Neuroimaging Market Attractiveness Analysis by Imaging Type, 2022-2032

Figure 47: South Asia Brain Imaging and Neuroimaging Market Attractiveness Analysis by End User, 2022-2032

Figure 48: South Asia Brain Imaging and Neuroimaging Market Attractiveness Analysis by Country, 2022-2032

Figure 49: East Asia Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 50: East Asia Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 51: East Asia Brain Imaging and Neuroimaging Market Value Share, By Country, 2022 (E)

Figure 52: East Asia Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2016-2021

Figure 53: East Asia Brain Imaging and Neuroimaging Market Value Forecast (US$ Mn), 2022-2032

Figure 54: East Asia Brain Imaging and Neuroimaging Market Attractiveness Analysis by Imaging Type, 2022-2032

Figure 55: East Asia Brain Imaging and Neuroimaging Market Attractiveness Analysis by End User, 2022-2032

Figure 56: East Asia Brain Imaging and Neuroimaging Market Attractiveness Analysis by Country, 2022-2032

Figure 57: Oceania Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 58: Oceania Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 59: Oceania Brain Imaging and Neuroimaging Market Value Share, By Country, 2022 (E)

Figure 60: Oceania Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2016-2021

Figure 61: Oceania Brain Imaging and Neuroimaging Market Value Forecast (US$ Mn), 2022-2032

Figure 62: Oceania Brain Imaging and Neuroimaging Market Attractiveness Analysis by Imaging Type, 2022-2032

Figure 63: Oceania Brain Imaging and Neuroimaging Market Attractiveness Analysis by End User, 2022-2032

Figure 64: Oceania Brain Imaging and Neuroimaging Market Attractiveness Analysis by Country, 2022-2032

Figure 65: Middle East and Africa Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 66: Middle East and Africa Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 67: Middle East and Africa Brain Imaging and Neuroimaging Market Value Share, By Country, 2022 (E)

Figure 68: Middle East and Africa Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2016-2021

Figure 69: Middle East and Africa Brain Imaging and Neuroimaging Market Value Forecast (US$ Mn), 2022-2032

Figure 70: Middle East and Africa Brain Imaging and Neuroimaging Market Attractiveness Analysis by Imaging Type, 2022-2032

Figure 71: Middle East and Africa Brain Imaging and Neuroimaging Market Attractiveness Analysis by End User, 2022-2032

Figure 72: Middle East and Africa Brain Imaging and Neuroimaging Market Attractiveness Analysis by Country, 2022-2032

Figure 73: U. S. Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032

Figure 74: U. S. Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 75: U. S. Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 76: Canada Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032

Figure 77: Canada Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 78: Canada Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 79: Mexico Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032

Figure 80: Mexico Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 81: Mexico Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 82: Brazil Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032

Figure 83: Brazil Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 84: Brazil Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 85: U. K. Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032

Figure 86: U. K. Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 87: U. K. Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 88: Germany Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032

Figure 89: Germany Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 90: Germany Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 91: France Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032

Figure 92: France Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 93: France Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 94: Italy Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032

Figure 95: Italy Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 96: Italy Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 97: Spain Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032

Figure 98: Spain Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 99: Spain Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 100: Russia Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032

Figure 101: Russia Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 102: Russia Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 103: China Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032

Figure 104: China Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 105: China Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 106: Japan Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032

Figure 107: Japan Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 108: Japan Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 109: South Korea Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032

Figure 110: South Korea Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 111: South Korea Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 112: India Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032

Figure 113: India Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 114: India Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 115: ASEAN Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032

Figure 116: ASEAN Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 117: ASEAN Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 118: Australia Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032

Figure 119: Australia Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 120: Australia Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 121: New Zealand Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032

Figure 122: New Zealand Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 123: New Zealand Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 124: GCC Countries Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032

Figure 125: GCC Countries Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 126: GCC Countries Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 127: Turkey Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032

Figure 128: Turkey Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 129: Turkey Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Figure 130: South Africa Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032

Figure 131: South Africa Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)

Figure 132: South Africa Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Brain Implants Market

Published : June 2022

Healthcare

Brain Metastasis Therapeutics Market

Published : April 2016

Healthcare

Brain Tumor Treatment Market

Published : January 1970

Healthcare

Brain Monitoring Systems Market

Published : March 2022

Google translate

Brain Imaging And Neuroimaging Market